FDA authorizes monoclonal antibody that tackles omicron
By
Alicia Lasek
Feb 15, 2022
Bebtelovimab is greenlit for treatment of mild to moderate COVID-19 in patients at high risk of severe disease. The move comes amid a federal push to increase supply of effective therapies.
CMS shares LTC booster data; coverage among residents meets national average
By
Alicia Lasek
Feb 10, 2022
Nursing home booster vaccination data is now available on the Medicare.gov Care Compare website as part of CMS’s effort to help increase facility vaccination coverage, the agency said Wednesday.
CMS warns states: Survey fully or suffer consequences
By
Kimberly Marselas
Feb 10, 2022
The Centers for Medicare & Medicaid Services Wednesday sternly warned state survey agencies they must enforce all aspects of the federal program’s health and safety requirements by long-standing agreement.
Study unveils ‘silent epidemic’ of loneliness among older women during pandemic
By
Alicia Lasek
Feb 09, 2022
Data from the Women’s Health Initiative show that rates of loneliness in women aged 70 and older have increased during the pandemic, with 19% reporting severe troubles, investigators say.
Night shift linked to insomnia and stress symptoms in nurses, study finds
By
Alicia Lasek
Feb 04, 2022
The effects of poor sleep shouldn’t be overlooked in nurses — especially those who work night shifts, investigators say.
You think we’re doing this for fun?
By
Renee Kinder
Feb 03, 2022
Two weeks ago, over her post-game Chick-fil-A, my 14-year-old put me in my place. I was, because I thought being a good mother required so, upset over the overly aggressive basketball schedule her father...
New COVID-19 test kits promised as LTC operators contend with shortages, slow PCR results
By
Alicia Lasek
Feb 03, 2022
Five million Celltion brand rapid tests will be shipped over a five-week period to facilities as they contend with testing supply shortages and slow lab turnaround times.
Unvaccinated have highest SARS-CoV-2 incidence, hospitalization
Feb 02, 2022
COVID-19 incidence and hospitalization rates are consistently higher for unvaccinated persons, and lowest for those fully vaccinated with a booster, according to research published Monday by the CDC.
After 20 years on the market, AbbVie’s dry-eye drug Restasis to be available as generic
By
Alicia Lasek
Feb 03, 2022
Dry eyes affect nearly 19% percent of adults aged 75 years and older, according to data from a national survey.
U.S. gives green light to Moderna’s COVID-19 vaccine
By
Alicia Lasek
Feb 01, 2022
“Spikevax” is the second COVID-19 mRNA vaccine to receive full FDA approval, following Pfizer-BioNTech’s Comirnaty in September.